FDA Stops Export of Americans' Cells for Foreign Genetic Engineering Trials
The FDA has halted new clinical trials involving the export of Americans' cells to foreign countries for genetic engineering due to concerns over lack of participant consent and potential misuse of genetic data by foreign governments, especially in light of recent exemptions that allowed such exports despite security risks.